Similar articles for PMID: 21979586

Year	Number of Results
2000	2
2002	4
2003	3
2004	7
2005	13
2006	8
2007	5
2008	6
2009	4
2010	7
2011	9
2012	8
2013	8
2014	7
2015	5
2016	2
2017	3
2018	3
2019	1
2021	3
2022	2
2024	0

1

Clinical relevance of TAp73 and ΔNp73 protein expression in ovarian cancer: a series of 83 cases and review of the literature.

Hofstetter G, Berger A, Chamson M, Müller-Holzner E, Reimer D, Ulmer H, Uramoto H, Marth C, Zeimet AG, Zeillinger R, Concin N. Hofstetter G, et al. Int J Gynecol Pathol. 2011 Nov;30(6):527-31. doi: 10.1097/PGP.0b013e31821ac519. Int J Gynecol Pathol. 2011. PMID: 21979586 Review.

2

Transdominant DeltaTAp73 isoforms are frequently up-regulated in ovarian cancer. Evidence for their role as epigenetic p53 inhibitors in vivo.

Concin N, Becker K, Slade N, Erster S, Mueller-Holzner E, Ulmer H, Daxenbichler G, Zeimet A, Zeillinger R, Marth C, Moll UM. Concin N, et al. Cancer Res. 2004 Apr 1;64(7):2449-60. doi: 10.1158/0008-5472.can-03-1060. Cancer Res. 2004. PMID: 15059898

3

Spatiotemporal switch from DeltaNp73 to TAp73 isoforms during nephrogenesis: impact on differentiation gene expression.

Saifudeen Z, Diavolitsis V, Stefkova J, Dipp S, Fan H, El-Dahr SS. Saifudeen Z, et al. J Biol Chem. 2005 Jun 17;280(24):23094-102. doi: 10.1074/jbc.M414575200. Epub 2005 Apr 1. J Biol Chem. 2005. PMID: 15805112 Free article.

4

Clinical relevance of dominant-negative p73 isoforms for responsiveness to chemotherapy and survival in ovarian cancer: evidence for a crucial p53-p73 cross-talk in vivo.

Concin N, Hofstetter G, Berger A, Gehmacher A, Reimer D, Watrowski R, Tong D, Schuster E, Hefler L, Heim K, Mueller-Holzner E, Marth C, Moll UM, Zeimet AG, Zeillinger R. Concin N, et al. Clin Cancer Res. 2005 Dec 1;11(23):8372-83. doi: 10.1158/1078-0432.CCR-05-0899. Clin Cancer Res. 2005. PMID: 16322298

5

Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.

Faridoni-Laurens L, Tourpin S, Alsafadi S, Barrois M, Temam S, Janot F, Koscielny S, Bosq J, Bénard J, Ahomadegbe JC. Faridoni-Laurens L, et al. Cell Cycle. 2008 Jun 1;7(11):1587-96. doi: 10.4161/cc.7.11.5894. Epub 2008 Mar 2. Cell Cycle. 2008. PMID: 18469517

6

DeltaNp73, a dominant-negative inhibitor of wild-type p53 and TAp73, is up-regulated in human tumors.

Zaika AI, Slade N, Erster SH, Sansome C, Joseph TW, Pearl M, Chalas E, Moll UM. Zaika AI, et al. J Exp Med. 2002 Sep 16;196(6):765-80. doi: 10.1084/jem.20020179. J Exp Med. 2002. PMID: 12235210 Free PMC article.

7

High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.

Lucena-Araujo AR, Kim HT, Thomé C, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Glória AB, Chauffaille Mde L, Athayde M, Chiattone CS, Mito I, Bendlin R, Souza C, Bortolheiro C, Coelho-Silva JL, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM. Lucena-Araujo AR, et al. Blood. 2015 Nov 12;126(20):2302-6. doi: 10.1182/blood-2015-01-623330. Epub 2015 Oct 1. Blood. 2015. PMID: 26429976 Free PMC article. Clinical Trial.

8

Aberrant expression of DeltaNp73 in benign and malignant tumours of the prostate: correlation with Gleason score.

Guan M, Chen Y. Guan M, et al. J Clin Pathol. 2005 Nov;58(11):1175-9. doi: 10.1136/jcp.2005.026955. J Clin Pathol. 2005. PMID: 16254107 Free PMC article.

9

DeltaTAp73 upregulation correlates with poor prognosis in human tumors: putative in vivo network involving p73 isoforms, p53, and E2F-1.

Domínguez G, García JM, Peña C, Silva J, García V, Martínez L, Maximiano C, Gómez ME, Rivera JA, García-Andrade C, Bonilla F. Domínguez G, et al. J Clin Oncol. 2006 Feb 10;24(5):805-15. doi: 10.1200/JCO.2005.02.2350. Epub 2005 Dec 27. J Clin Oncol. 2006. PMID: 16380414

10

Expression levels of p53 and p73 isoforms in stage I and stage III ovarian cancer.

Marabese M, Marchini S, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Signorelli M, Moll UM, Codegoni AM, Broggini M. Marabese M, et al. Eur J Cancer. 2008 Jan;44(1):131-41. doi: 10.1016/j.ejca.2007.10.011. Epub 2007 Nov 26. Eur J Cancer. 2008. PMID: 18039564 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year